{"lastClose": 1.3300000429153442, "len": 493, "date": "2023-03-31", "alpha_1": -0.608715014420365, "beta_1": 2.5606231279092553, "drawup_1": 0.6999999674883763, "natr_1": 35.12691311081954, "sup_1": -0.045112767353339266, "res_1": 0.6090225235936537, "bullPattern_1": ["SHORTLINE"], "bearPattern_1": [], "rsi_1": 34.591193836864406, "adx_1": 55.87088209140219, "drawdown_1": -0.7142856899572867, "stratHoldSharpe_1": -0.6961436698459741, "stratHoldAlpha_1": 250.41889569192932, "stratHoldDrawdown_1": -0.6454697305003605, "alpha_3mo": -0.8556851558963064, "beta_3mo": 2.8753477632182847, "drawup_3mo": 0.44078952940877514, "natr_3mo": 35.12691311081954, "sup_3mo": -0.21553884374820634, "res_3mo": 0.042606504160209925, "bullPattern_3mo": [], "bearPattern_3mo": [], "rsi_3mo": 48.529412795928366, "adx_3mo": 17.80029717343384, "drawdown_3mo": -0.452054787063909, "stratHoldSharpe_3mo": -0.443152057793501, "stratHoldAlpha_3mo": 250.6581855787658, "stratHoldDrawdown_3mo": -0.41870300038737984, "Country": "United States", "Industry": "Biotechnology: Biological Products (No Diagnostic Substances)", "IPO Year": 2021.0, "Sector": "Health Care", "Market Cap": 2731074703, "Name": "Ginkgo Bioworks Holdings Inc. Class A", "alpha%_1": 0.03182772939349498, "beta%_1": 0.9994526952647622, "drawup%_1": 0.6598172163309943, "natr%_1": 1.0, "drawdown%_1": 0.040218606320647846, "stratHoldSharpe%_1": 0.18319686270177776, "stratHoldAlpha%_1": 0.015415894059584748, "stratHoldDrawdown%_1": 0.04247143487073541, "alpha%_3mo": 0.08927812400077617, "beta%_3mo": 0.9995185672700445, "drawup%_3mo": 0.9567000369028831, "natr%_3mo": 1.0, "drawdown%_3mo": 0.011616728671933226, "stratHoldSharpe%_3mo": 0.27581603498343665, "stratHoldAlpha%_3mo": 0.19846316693244653, "stratHoldDrawdown%_3mo": 0.010244092467916618}